rs1935949 — FOXO3

FOXO3's Second Longevity Signal — A Distinct Regulatory Haplotype

FOXO3 is one of only two human genes — along with APOE — whose longevity associations have been consistently replicated across multiple independent populations and ancestries. The first FOXO3 signal, rs2802292¹¹ rs2802292
the well-characterized HSF1-binding enhancer variant in intron 2, has been studied intensively since 2008. But FOXO3's longevity architecture is more complex: rs1935949 tags a second, independent haplotype block spanning 121 kilobases of FOXO3 intron 3 that independently contributes to centenarian enrichment through a distinct regulatory mechanism.

Pawlikowska et al. 2009²² Pawlikowska et al. 2009
Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell. 2009 identified rs1935949 among longevity-associated variants across three Caucasian cohorts — the Study of Osteoporotic Fractures, the Cardiovascular Health Study, and Ashkenazi Jewish Centenarians — finding a significant longevity association in women (OR = 1.35, 95% CI 1.15–1.57, adjusted p = 0.0093).

The Mechanism

rs1935949 sits in intron 3 of FOXO3, approximately 1.7 kilobase-pairs from an intron-exon boundary, and is in strong linkage disequilibrium (r² = 0.96) with rs4946935 — the functionally characterized variant in the same haplotype block. Flachsbart et al. 2017³³ Flachsbart et al. 2017
Identification and characterization of two functional variants in the human longevity gene FOXO3. Nat Commun. 2017 demonstrated that the longevity allele of rs4946935 creates an allele-dependent binding site for serum response factor (SRF) — a transcription factor distinct from the heat shock factor 1 (HSF1) that binds the rs2802292 site. In luciferase reporter assays, the longevity alleles at rs4946935 (and by proxy, rs1935949) show substantial enhancer activity that is specifically reversed by IGF-1 treatment.

This IGF-1 reversibility is mechanistically significant. The insulin/IGF-1 signaling (IIS) pathway⁴⁴ insulin/IGF-1 signaling (IIS) pathway
the PI3K-AKT cascade that phosphorylates and excludes FOXO3 from the nucleus is the primary evolutionary brake on FOXO3 activity: high IGF-1 levels drive AKT activation, which phosphorylates FOXO3 and traps it in the cytoplasm, preventing it from activating stress-response and longevity genes. The longevity allele at rs1935949's haplotype creates an enhancer that is most active when IGF-1 is low — exactly the dietary and metabolic condition under which FOXO3's protective functions matter most. This explains why the variant was first identified in a study of IGF-1 signaling pathway genetics and why its effects are magnified by caloric restriction and fasting contexts.

An eQTL database search confirms that the longevity alleles associated with the rs1935949/rs4946935 haplotype block are associated with higher FOXO3 mRNA expression across multiple human tissues, consistent with the enhancer model. The haplotype containing rs1935949 (haplotype block 1, alongside rs13217795, rs2764264, rs9400239, and rs9486902, D'>0.86 spanning 121 kb) is structurally distinct⁵⁵ structurally distinct
the haplotype blocks were identified by LD analysis across 12 FOXO3 SNPs from the block containing rs2802292, allowing independent additive effects on longevity.

The Evidence

Bao et al. 2014⁶⁶ Bao et al. 2014
Association between FOXO3A gene polymorphisms and human longevity: a meta-analysis. Asian J Androl. 2014 pooled five of its eleven studies that genotyped rs1935949, encompassing 1,435 cases and 2,098 controls, finding significant overall longevity association (OR = 1.14, 95% CI 1.01–1.27). Gender-stratified results suggested the overall association was not driven primarily by females in this cohort, though the sex-specific picture is complex and differs across studies.

The largest replication effort comes from Bae et al. 2018⁷⁷ Bae et al. 2018
Effects of FOXO3 polymorphisms on survival to extreme longevity in four centenarian studies. J Gerontol A Biol Sci Med Sci. 2018, which analyzed 2,072 cases and 6,194 controls across the Long Life Family Study, New England Centenarian Study, Southern Italian Centenarian Study, and Longevity Genes Project. rs1935949 showed a meta-analysis beta of 0.18 (SE 0.044, p = 6.60×10⁻⁵), corresponding to approximately OR = 1.20 for extreme longevity (defined as surviving to the oldest 1 percentile of the 1900 U.S. birth cohort — ≥96 years for males, ≥100 for females). Centenarian enrichment of the protective A allele was observed in all four cohorts, though effect sizes varied.

Evidence is strongest in Caucasian populations. Studies in Chinese Han populations did not replicate the rs1935949 association, consistent with population-specific LD patterns and potentially different regulatory architectures across ancestries.

Practical Implications

The IGF-1-reversible nature of this haplotype's regulatory effect suggests a dietary angle that is more explicit than for rs2802292. Dietary interventions that lower circulating IGF-1 — particularly plant-protein-predominant diets and periodic fasting — reduce IGF-1-mediated suppression of FOXO3 at this enhancer. Caloric restriction extending maximum lifespan in model organisms is mechanistically connected to reduced IIS signaling and consequent FOXO3 activation; the rs1935949 haplotype may amplify this response.

The additive architecture of FOXO3 longevity signals is worth appreciating. Individuals who carry protective alleles at both rs1935949 and rs2802292 benefit from independent contributions to FOXO3 expression through distinct transcription factor binding sites (SRF at the rs4946935/rs1935949 haplotype; HSF1 at rs2802292). The two mechanisms respond to different cellular stresses — nutrient status for the IGF-1-sensitive haplotype, heat shock and oxidative stress for the HSF1 site — making them genuinely complementary.

Interactions

rs1935949 and rs2802292 are in different haplotype blocks across FOXO3 and have independent longevity effects. Individuals carrying protective alleles at both loci likely experience additive longevity benefit through distinct molecular mechanisms (SRF-mediated nutrient-sensing regulation vs. HSF1-mediated stress response regulation). A compound action is worth considering for individuals carrying beneficial alleles at both rsids, as the combined message — targeting both IGF-1 reduction and stress-response activation — is more specific than either alone.

rs4946935 (r² = 0.96 with rs1935949) is the functional proxy variant for the enhancer mechanism; individuals who have both in their genome data will likely have concordant results. rs13217795, also in haplotype block 1, has been separately shown to regulate an alternative FOXO3 promoter (FOXO3-TR isoform expression), adding another regulatory dimension to the same haplotype block.